E3	Condition:T3 Name:T4 Temporality:E7
E4	Eq-Comparison:T13 Operator:T5 Temporal-Unit:T7 Value:T12
E5	Eq-Comparison:T14 Temporal-Period:T15
E6	Eq-Comparison:T16 Temporal-Period:T17
E2	Modifier:T18 Modifies:T4
E7	Eq-Comparison:T19 Operator:T20 Temporal-Unit:T6 Value:T8
E8	Drug:T21 Name:T22
E9	Temporal-Connection:T23 Arg:E7 Arg2:E8
E10	Procedure:T24
E11	And:T25 Arg:E8 Arg2:E10
E12	Procedure:T26 Temporality:E14
E13	Drug:T27 Name:T28
E14	Eq-Comparison:T29 Temporal-Period:T30
E15	Procedure:T10
E16	Drug:T31 Name:T32
E17	Assertion:T33 Asserted:E15
E18	Observation:T34 Name:T35 Eq-Comparison:E19 Minimum-Count:E1
E19	Eq-Comparison:T36 Operator:T37 Value:T38 Unit:T39
E1	Eq-Comparison:T1 Operator:T2 Value:T11 Unit:T40
E20	Observation:T41 Name:T42 Eq-Comparison:E21
E21	Eq-Comparison:T43 Operator:T44 Unit:T45
E22	Or:T46 Arg:E18 Arg2:E20
E23	Condition:T47 Name:T48
E24	Risk:T49 Risk-For:E23 Minimum-Count:E25 Severity:T53
E25	Eq-Comparison:T50 Value:T51 Operator:T52
E26	Drug:T54 Name:T55 Temporality:E6 Temporality2:E4
T3	Condition 75 71	pemphigoid
T4	Condition-Name 75 71	pemphigoid
T5	Eq-Operator 913 892	less than
T6	Eq-Temporal-Unit 123 118	months
T7	Eq-Temporal-Unit 923 901	months
T8	Eq-Value 116 111	3
T12	Eq-Value 916 894	3
T13	Eq-Comparison 923 901	less than 3 months
T14	Eq-Comparison 333 326	received
T15	Eq-Temporal-Period 333 326	received
T16	Eq-Comparison 876 855	received
T17	Eq-Temporal-Period 876 855	received
T18	Modifier 64 60	multi-bullous
T19	Eq-Comparison 123 118	more than 3 months
T20	Eq-Operator 113 109	more than
T21	Drug 154 149	corticosteroids
T22	Drug-Name 154 149	corticosteroids
T23	Temporal-Connection 129 124	after
T24	Procedure 166 161	treated
T25	And 158 153	and
T9	Insurance 441 434	national health insurance
T26	Procedure 603 592	treatment
T27	Drug 593 582	anti-osteoporotic
T28	Drug-Name 593 582	anti-osteoporotic
T29	Eq-Comparison 570 561	receiving
T30	Eq-Temporal-Period 570 561	receiving
T10	Procedure 669 656	treatment
T31	Drug 650 637	anti-osteoporotic
T32	Drug-Name 650 637	anti-osteoporotic
T33	Assertion 627 616	requiring
T34	Observation 681 665	T-score
T35	Observation-Name 681 665	T-score
T36	Eq-Comparison 691 672	⩽ -3DS
T37	Eq-Operator 683 667	⩽
T38	Eq-Value 688 670	-3
T39	Eq-Unit 691 672	DS
T1	Eq-Comparison 711 691	at least 1 site
T2	Eq-Operator 703 684	at least
T11	Eq-Value 706 686	1
T40	Eq-Unit 711 691	site
T41	Observation 725 705	FRAX score
T42	Observation-Name 725 705	FRAX score
T43	Eq-Comparison 770 750	above the therapeutic intervention threshold
T44	Eq-Operator 731 711	above
T45	Eq-Unit 770 750	therapeutic intervention threshold
T46	Or 714 694	or
T47	Condition 844 823	osteoporosis
T48	Condition-Name 844 823	osteoporosis
T49	Risk 819 798	risk
T50	Eq-Comparison 808 787	one or more
T51	Eq-Value 800 779	one
T52	Eq-Operator 808 787	or more
T53	Severity 814 793	major
T54	Drug 900 879	topical corticosteroids
T55	Drug-Name 900 879	topical corticosteroids
A1	Eq-Operator-Value T5 LT
A2	Eq-Temporal-Unit-Value T6 month
A3	Eq-Temporal-Unit-Value T7 month
A4	Eq-Temporal-Period-Value T15 past
A5	Eq-Temporal-Period-Value T17 past
A6	Eq-Operator-Value T20 GT
A7	Temporal-Connection-Type-Value E9 after
A8	Eq-Temporal-Period-Value T30 present
A9	Assertion-Type-Value E17 hypothetical
A10	Eq-Operator-Value T37 LTEQ
A11	Eq-Operator-Value T2 GTEQ
A12	Observation-Type-Value T35 measurement
A13	Observation-Type-Value T42 clinical-score
A14	Eq-Operator-Value T44 GT
A15	Eq-Unit-Value T45 ref-range-high
A16	Eq-Operator-Value T52 GTEQ
A17	Severity-Value T53 severe
R1	Treatment-For Arg1:E10 Arg2:E3
R2	Using Arg1:E12 Arg2:E13
R3	Using Arg1:E15 Arg2:E16